Natural products and long noncoding RNA signatures in gallbladder cancer: a review focuses on pathogenesis, diagnosis, and drug resistance-Reference-Cited by-同舟云学术

Natural products and long noncoding RNA signatures in gallbladder cancer: a review focuses on pathogenesis, diagnosis, and drug resistance

Published:2024-07-19 Issue: Volume: Page:
ISSN:0028-1298
Container-title:Naunyn-Schmiedeberg's Archives of Pharmacology
language:en
Short-container-title:Naunyn-Schmiedeberg's Arch Pharmacol

Author:

Elimam Hanan^ORCID,Alhamshry Nora A. A.,Hatawsh Abdulrahman,Elfar Nourhan,Moussa Rewan,Radwan Abdullah F.,Abd-Elmawla Mai A.,Elkashlan Akram M.,Zaki Mohamed Bakr,Abdel-Reheim Mustafa Ahmed^ORCID,Mohammed Osama A.,Doghish Ahmed S

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00210-024-03279-1.pdf

Reference157 articles.

1. Abd-Elmawla MA, Hassan M, Elsabagh YA, Alnaggar ARL, Senousy MA (2020) Deregulation of long noncoding RNAs ANCR, TINCR, HOTTIP and SPRY4-IT1 in plasma of systemic sclerosis patients: SPRY4-IT1 as a novel biomarker of scleroderma and its subtypes. Cytokine 133:155124

2. Abd-Elmawla MA, Elsabagh YA, Aborehab NM (2023) Association of XIST/miRNA155/Gab2/TAK1 cascade with the pathogenesis of anti-phospholipid syndrome and its effect on cell adhesion molecules and inflammatory mediators. Sci Rep 13:18790

3. Adamska A, Domenichini A, Falasca M (2017) Pancreatic ductal adenocarcinoma: current and evolving therapies. Int J Mol Sci 18:1338–1338

4. Alvarez-Dominguez JR, Lodish HF (2017) Emerging mechanisms of long noncoding RNA function during normal and malignant hematopoiesis. Blood 130:1965–1975

5. Arslan C, Yalcin S (2014) Current and future systemic treatment options in metastatic pancreatic cancer. J Gastrointest Oncol 5:280–280